Bio Solution Co

Bio Solution Co Rule of 40

The Rule of 40 of Bio Solution Co (086820.KQ) as of Oct 23, 2026 is 35.69 %. In the previous year, Rule of 40 was -75.45 % — a change of -147.31% (higher).

Rule of 40

35.69 %

YoY

-147.31%

Last updated:

Rule of 40 of Bio Solution Co is 2025 35.69 % . Rule of 40 of Bio Solution Co was 2024 -75.45 % . It decreases by -147.31% higher compared to the previous year.

The Bio Solution Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
120.35 KRW
Jan 1, 2019
-36.64 KRW
Jan 1, 2020
-55.81 KRW
Jan 1, 2021
39.08 KRW
Jan 1, 2022
-83.82 KRW
Jan 1, 2023
-17.89 KRW
Jan 1, 2024
-75.45 KRW
Jan 1, 2025
35.69 KRW
The Bio Solution Co Rule of 40 history
YEARRule of 40YoY
35.69 %-147.31%
-75.45 %+321.72%
-17.89 %-78.66%
-83.82 %-314.46%
39.08 %-170.02%
-55.81 %+52.35%
-36.64 %-130.44%
120.35 %+496.20%
20.19 %-140.37%
-50.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Solution Co Stock analysis

What does Bio Solution Co do? Bio Solution Co. Ltd. generates revenue through the manufacturing and distribution of cell therapy products and stem cell applied technologies. The company sells stem water, a cosmetic raw material containing human stem cells with whitening and anti-wrinkling effects, and keratinocyte medication for severe burns. Additionally, it offers chondrocyte therapy for arthritis treatment and develops human tissue models for toxicity and efficacy testing. The primary customers are cosmetic manufacturers and medical institutions seeking advanced therapeutic solutions. The firm's product portfolio includes stem water, keratinocyte medication, and chondrocyte therapy, all leveraging tissue engineering and stem cell technologies. These products target the cosmetic and medical sectors, with stem water appealing to the skincare market and keratinocyte and chondrocyte therapies serving medical applications. The company focuses on developing and commercializing cell-based solutions for both cosmetic and therapeutic uses. Bio Solution Co. Ltd. operates within the cell therapy and stem cell technology sector, providing specialized products that combine tissue engineering with stem cell applications. Its revenue streams are derived from the sale of cosmetic raw materials and medical therapeutics, with an emphasis on innovative, science-backed solutions for skin care and medical treatments. Bio Solution Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Solution Co stock

Rule of 40 of Bio Solution Co is 35.69 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Bio Solution Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Bio Solution Co

All Key Metrics — Bio Solution Co